LEP and diabetes mellitus: Contrary to their finding, Morton and his colleagues argue that the HPA-axis does not contribute to glucose-lowering effects of leptin because (i) STZ administrations cause diabetes in adrenalectomized rats, and (ii) corticosterone administration in adrenalectomized rats does not reverse the glucose-lowering effects of leptin (61).